Health Trials

Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

PulseMagic™ TrueForce™ PAF NMPA Study

This clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort EP MedTech Co., Ltd.Updated: Jul 22, 2026Locations: 1
Eligibility criteria

Aged ≥ 18 years old. [+4]

Patients with a history of atrial fibrillation ablation. [+9]

Read more
Status: Not yet recruiting

Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications

The primary objective of this study was to evaluate the clinical feasibility, safety, and surgical characteristics of the EasyStars™ High Density Mapping Catheterin in patients with complex arrhythmias.

Participants needed: 300
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort EP MedTech Co., Ltd.Updated: Jul 31, 2025
Eligibility criteria

Clinical diagnosis: Ventricular tachycardia (VT) [+6]

Uncontrolled heart failure (New York Heart Association functional class III-IV); [+42]

Read more
Status: Not yet recruiting

Clinical Study on the Safety and Efficacy of a New Magnetic Navigation Radiofrequency Ablation Catheter for Rapid Arrhythmia

Clinical study on the safety and efficacy of FireMagic™ Magbot Ablation Catheter for rapid arrhythmia

Participants needed: 20
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort EP MedTech Co., Ltd.Updated: Jul 16, 2025Locations: 1
Eligibility criteria

1) Patients aged 18 to 80 years old, with no gender restrictions; 2) Patients cl...

1) Left atrial thrombus (not applicable for PSVT); 2) Left atrial anteroposterio...

Read more
Status: Not yet recruiting

A Clinical Study on the Use of a Domestically Produced Three-dimensional Cardiac Electrophysiological Mapping System Combined With Pressure Monitoring Technology and Star Mapping Technology for the Treatment of Paroxysmal Atrial Fibrillation.

Validating the safety and efficacy of pressure monitoring technology and star-shaped marking technology for the treatment of paroxysmal atrial fibrillation

Participants needed: 20
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort EP MedTech Co., Ltd.Updated: Jun 27, 2025Locations: 1
Eligibility criteria

Patient age between 18 and 80 years old, male or non-pregnant female. [+2]

Post-ablation for atrial fibrillation [+11]

Read more
Status: Not yet recruiting

A Clinical Study on the Use of a Domestically Produced Cryoablation System Combined With Balloon Cryoablation Technology for the Treatment of Paroxysmal Atrial Fibrillation

To validate the safety and efficacy of balloon cryoablation technology and the accompanying disposable intracardiac mapping electrode catheter and adjustable guide sheath for the treatment of paroxysmal atrial fibrillation.

Participants needed: 20
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort EP MedTech Co., Ltd.Updated: Jun 27, 2025Locations: 1
Eligibility criteria

Patient age between 18 and 80 years old, male or non-pregnant female. [+2]

Patients who have undergone atrial fibrillation ablation surgery [+11]

Read more
Status: Not yet recruiting

Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function

This project aims to evaluate the safety, efficacy, and cost-effectiveness of using FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter to treat rapid arrhythmias.

Participants needed: 300
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort EP MedTech Co., Ltd.Updated: Jun 24, 2025
Eligibility criteria

Confirmed diagnosis of supraventricular tachycardia or atrial fibrillation requi... [+2]

Left atrial size ≥50 mm, left ventricular ejection fraction ≤40%; [+16]

Read more